Let me tell you a story…
She was one of the sharpest leaders I’d ever seen. Ran a division of 400 people. Presented to the board without notes. Made decisions under pressure the way most people breathe — automatically, cleanly, without hesitation.
Then perimenopause hit.
Within eighteen months, she was blanking on words mid-sentence. Canceling speaking engagements she would have owned two years prior. Waking at 3am with her heart pounding, convinced something was wrong. Quietly asking herself whether she still had what it took.
No one connected the dots. Not her internist. Not her therapist. Not her company.
She wasn’t declining, her hormones were.
The Problem No One Is Naming
Menopause and work performance are on a collision course that no one is adequately addressing. We are losing the most experienced, highest-performing women in the workforce at the exact moment they should be at peak influence. Not because they chose to leave. Not because they lost their edge. But because they were performing on a depleted system — and nobody gave them the information, the support, or the language to understand what was happening inside their own bodies.
Women executives don’t leave because they’re done. They leave because they didn’t have the information, support, or language to stay.
Perimenopause — the transitional phase leading into menopause — typically begins in a woman’s early-to-mid 40s. For many high-performing women, this coincides with peak career visibility: board seats, C-suite roles, keynote stages, the moments they’ve built toward for decades.
This collision between hormonal transition and professional peak is one of the most underdiscussed crises in women’s health and workplace equity today.
What’s Actually Happening: Menopause, Work Performance, and the Brain
Here is what most conventional medicine misses — and what changes everything once you understand it:
Estrogen and progesterone are not just reproductive hormones. They are neurological hormones.
They directly govern serotonin, dopamine, GABA, acetylcholine, and mitochondrial energy production — the exact biological machinery that powers cognitive performance, emotional regulation, stress resilience, and sustained energy. When they decline, the brain and body that a woman has relied on for her entire career begin to operate differently.
This is not burnout in the conventional sense. This is a physiological system change menopause and work performance cannot be separated when you understand the neuroscience.
The Brain: Estrogen, Cognition, and the Prefrontal Cortex
Research consistently shows that verbal learning and verbal memory are the cognitive functions most negatively affected during perimenopause — with newer studies documenting deficits in processing speed, attention, and working memory as well. Critically, these declines are not explained by advancing age alone.
Here is the mechanism: estrogen has direct neuroprotective effects on the prefrontal cortex — the region of the brain governing decision-making, strategic thinking, and executive function. It modulates blood flow and metabolic efficiency in this area. When estrogen drops, so does the brain’s capacity to operate at its previous level in precisely the cognitive domains that define executive performance.
From a neuroscience perspective, menopause-related brain fog is not an isolated symptom. It is a convergence point — where sleep disruption, vasomotor symptoms, stress physiology, mood changes, and hormonal shift interact to amplify day-to-day variability in attention and memory. The woman who blanks on a word mid-presentation is not losing her mind. She is experiencing a measurable, documented neurological response to hormonal change.
The Nervous System: Progesterone and the GABA Connection
Progesterone is the hormone that typically drops first — often beginning its decline in the mid-to-late 30s, well before estrogen becomes erratic. It is also the hormone most consistently overlooked in the conversation about menopause.
Once in the brain, progesterone converts into allopregnanolone — a compound that activates GABA-A receptors, the same receptors targeted by benzodiazepines. This produces a calming, sedative effect on the central nervous system. In plain terms: progesterone is the brain’s endogenous anti-anxiety compound. Women’s nervous systems have been receiving this input for decades.
When progesterone drops, so does allopregnanolone, and with it GABA receptor activation. The documented consequences include altered cognitive functioning, mood instability, insomnia, and increased susceptibility to anxiety and depression. The persistent, low-grade anxiety that executive women describe — the kind that makes a board presentation feel disproportionately heavy, or a difficult conversation feel impossible to navigate — is a neurochemical deficit with a measurable biological cause.
Progesterone also has an inverse relationship with cortisol. When progesterone is low, cortisol rises. For a woman already operating in a high-demand professional environment, the loss of progesterone removes the biological counterweight to her stress response. Stress becomes harder to metabolize, recover from, and contextualize. What looks like burnout from the outside is often a hormonal system in physiological crisis.
Mood, Anxiety, and Depression: The Hormonal Root Cause That Gets Missed
A 2023 systematic review concluded that menopause increases vulnerability to depression and anxiety through estrogen fluctuations affecting serotonin and GABA — two of the brain’s primary mood-stabilizing neurotransmitters. Women with a prior history of depression carry a 70% higher risk of experiencing menopausal depression.
A 2024 network meta-analysis found that combining systemic estradiol with antidepressants yielded significantly higher remission rates than antidepressants alone. This is not a minor finding. It points directly to estrogen’s role in mood regulation as a primary driver.
The clinical gap is significant: the majority of women in this phase who present with anxiety or depression are being treated for those conditions in isolation. The hormonal connection is under explored with the result is years of mismanagement — with isolated treatments and prescriptions that are trying to address one piece of the puzzle.
Focus, ADHD, and Dopamine: The Most Underreported Intersection
Estrogen modulates dopamine — the neurotransmitter central to focus, motivation, and executive functioning. As estrogen declines, dopaminergic tone in the prefrontal circuits declines with it.
This manifests as intensified symptoms of emotional dysregulation, disorganization, inattention, and impaired short-term memory. For women who previously managed ADHD symptoms effectively — often without a formal diagnosis, because estrogen was compensating — menopause can initiate a period of dramatically increase in= symptoms.
Many women receiving new ADHD diagnoses in their 40s and 50s are not newly developing the condition. They are losing the hormonal buffer that was masking it. The distinction matters — because the treatment approach is different, and the window for intervention is specific.
Energy and Fatigue: What the Mitochondria Have to Do With It
Estrogen plays a direct role in mitochondrial function — the cellular machinery that converts food into usable energy. When estrogen declines, mitochondrial efficiency drops. The body must work harder to produce the same output. The result is a fatigue that rest does not fix — because it is not just caused by insufficient sleep. It can be caused by insufficient cellular energy production.
Because the brain consumes approximately 20% of the body’s total energy output despite representing only 2% of body weight, the decline in mitochondrial function hits cognitive performance disproportionately hard. The executive who cannot get through an afternoon without hitting a cognitive wall is not lacking discipline. Her cells are producing less fuel.
Research documents that 40% of women in perimenopause experience sleep disturbances — compounding an already compromised energy system. Low progesterone directly reduces sleep efficiency, shortens total sleep time, and increases wakefulness after sleep onset. Both hormones are contributing simultaneously, through different mechanisms, to the same outcome: a woman showing up to her most demanding professional moments already running on empty.
The Silence That Makes It Worse
The physiology is only part of the problem. The other part is the silence surrounding it.
There is no vocabulary for this conversation in most workplaces. No framework. No policy. Women at the top of their organizations — women who have navigated every other challenge their careers have presented — are navigating this one completely alone.
They fear that naming what is happening will be career-limiting. That disclosing a hormonal shift will be read as instability, weakness, or declining capability. So they don’t name it. They compensate. They white-knuckle through presentations, reschedule calls, pull back from visibility, and quietly begin self-selecting out of the rooms they should be walking into with full authority.
Healthcare providers are not reliably filling this gap. Many women report being dismissed, normalized, or handed a prescription for anxiety or depression without the hormonal connection ever being explored. Years pass. The window for early intervention narrows. The symptoms compound.
The pipeline paradox: companies invest in women’s leadership pipelines while losing their most experienced women out the back door — during the exact window when symptoms are worst, and most treatable.
What Becomes Possible When the Biology Is Addressed
This is not a story about decline. It is a story about an information gap — and what closes when that gap is addressed.
When the hormonal root cause is identified and treated with precision, the trajectory changes. Brain fog lifts. Word retrieval returns. Strategic thinking sharpens. Sleep becomes restorative again. Anxiety drops to a level that is proportionate to actual circumstances. Energy stabilizes across a full day — not artificially, not through stimulants, but because the underlying cellular machinery is working again.
The women I work with do not become different people when their hormones are optimized. They become themselves again — often a sharper, more self-aware, more strategically clear version than before. The wisdom that comes from navigating this transition intentionally is genuinely compounding. What they lose in hormonal chaos, they gain in clarity about what matters, what they want, and what they are willing to tolerate.
They stop quietly self-selecting out. They start walking back into rooms.
The Compounding Effect of Getting This Right
When high-performing women get the hormonal support they needed years earlier, the professional restoration is real. Returning to full presence in board rooms, on stages, in high-visibility roles. Pursuing promotions, board seats, and expanded platforms they had been avoiding. Performing at or above previous standards — with the added dimension of having navigated something significant.
And beyond the individual: these women become the leaders who change the conversation in their organizations. The ones who name it, who build policy around it, who ensure the next generation of women leaders does not face this in silence.
Longevity is part of this picture too. When hormonal health is addressed at the perimenopause window — not after a decade of mismanagement — the downstream benefits extend into cardiovascular health, bone density, metabolic resilience, and cognitive protection. We are not talking about symptom management. We are talking about health creation across decades.
Why This Requires a Different Kind of Doctor
In a medical world defined by hyper-specialization, no one is putting it all together.
Your cardiologist sees the palpitations. Your psychiatrist sees the anxiety. Your gynecologist sees the hormonal shift. Your neurologist sees the cognitive complaints. Each operates within their lane. None of them is looking at the full mosaic — at how estrogen, progesterone, cortisol, dopamine, mitochondrial function, and sleep architecture are interacting as a single system to produce what you are experiencing.
That integration is what I do.
I have worked with thousands women through every phase of hormonal change — using herbs, diet, and lifestyle modifications at one end of the spectrum, and bioidentical hormone therapy at the other, and everything in between. The approach is not ideological. It is mechanistic. It is specific to each woman’s biology, her unique hormonal pattern, her goals, her professional demands, and the legacy she is building.
I am not interested in getting you to feeling better. Feeling better is Phase 1. What I am building toward is a new baseline — one that matches your ambition, supports your capacity, and holds under pressure.
Feeling better is not the same as being healthy. Health creation — not symptom management — is the standard.
If This Is You — Here’s Where to Start
If you are reading this and recognizing yourself — in the brain fog, the anxiety, the fatigue, the quiet retreat from the rooms you built your career to occupy — I want you to understand one thing clearly:
This is not who you are becoming. This is what happens when a high-performing woman runs on a depleted hormonal system without the right support. And it is addressable.
This week is National Naturopathic Medicine Week — a fitting moment to have a conversation that conventional medicine has largely left on the table. Naturopathic medicine is built on exactly this kind of work: identifying the root cause, evaluating the whole system, and building a clinical strategy that is specific to your biology — not a protocol designed for the average patient.
A hormone checkup is where this starts. Not a standard panel that tells you your levels are within normal range and sends you home. A functional evaluation that looks at how your specific hormonal pattern — estrogen, progesterone, cortisol, thyroid, testosterone — is interacting across every system that governs how you think, lead, sleep, and perform.
The window for this work matters. The earlier hormonal decline is identified and addressed, the more complete the restoration — and the more protected your cognitive function, cardiovascular health, and metabolic resilience are for the decades ahead. This is not a conversation to defer until symptoms become impossible to ignore.
Schedule your hormone checkup today.
You did not build this career to walk away from it. You built it to lead from it — fully, for as long as you choose. That requires your biology working with you, not against you.